PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 2 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,048,000 | +1.7% | 3,368,052 | +9.4% | 0.00% | 0.0% |
| Q1 2017 | $2,013,000 | +163.8% | 3,077,652 | +24.4% | 0.00% | +200.0% |
| Q4 2016 | $763,000 | -28.0% | 2,473,846 | +0.5% | 0.00% | -50.0% |
| Q3 2016 | $1,059,000 | +115.2% | 2,462,446 | +82.3% | 0.00% | +100.0% |
| Q2 2016 | $492,000 | -6.8% | 1,350,952 | +7.7% | 0.00% | 0.0% |
| Q1 2016 | $528,000 | -67.6% | 1,254,752 | -10.0% | 0.00% | -75.0% |
| Q4 2015 | $1,632,000 | +574.4% | 1,394,722 | +488.1% | 0.00% | +300.0% |
| Q3 2015 | $242,000 | -87.3% | 237,152 | -83.7% | 0.00% | -75.0% |
| Q2 2015 | $1,910,000 | +1347.0% | 1,458,251 | +1429.9% | 0.00% | – |
| Q4 2013 | $132,000 | – | 95,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |